Literature DB >> 7793080

MHV-A59 enters polarized murine epithelial cells through the apical surface but is released basolaterally.

J W Rossen1, W F Voorhout, M C Horzinek, A van der Ende, G J Strous, P J Rottier.   

Abstract

Coronaviruses have a marked tropism for epithelial cells. Entry and release of the porcine transmissible gastroenteritis virus (TGEV) is restricted to apical surfaces of polarized epithelial cells, as we have recently shown (J. W. A. Rossen, C. P. J. Bekker, W. F. Voorhout, G. J. A. M. Strous, A. van der Ende, and P. J. M. Rottier, 1994, J. Virol. 68, 7966-7973). In this paper we analyze the interactions of mouse hepatitis coronavirus A59 (MHV-A59) with polarized murine kidney cells (mTAL) grown on permeable supports. After inoculation from the apical or basolateral side, virus entry was found to take place only through the apical membrane. The virus utilized a protein of the carcinoembryonic antigen family as its receptor. In contrast to TGEV, MHV-A59 was released preferentially from the basolateral plasma membrane domain, as evidenced by the accumulation of viral proteins and infectivity in the basolateral culture fluid as well as by electron microscopical observations. In the mouse, MHV initially replicates in the nasal epithelium before being disseminated throughout the body; the basolateral release of MHV from epithelial cells into the animal's circulation may be the first step in the establishment of a systemic infection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7793080      PMCID: PMC7130697          DOI: 10.1006/viro.1995.1316

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  12 in total

1.  Rotavirus is released from the apical surface of cultured human intestinal cells through nonconventional vesicular transport that bypasses the Golgi apparatus.

Authors:  N Jourdan; M Maurice; D Delautier; A M Quero; A L Servin; G Trugnan
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Retargeting of coronavirus by substitution of the spike glycoprotein ectodomain: crossing the host cell species barrier.

Authors:  L Kuo; G J Godeke; M J Raamsman; P S Masters; P J Rottier
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia.

Authors:  Hong Peng Jia; Dwight C Look; Lei Shi; Melissa Hickey; Lecia Pewe; Jason Netland; Michael Farzan; Christine Wohlford-Lenane; Stanley Perlman; Paul B McCray
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

Review 4.  Sialic acids as receptor determinants for coronaviruses.

Authors:  Christel Schwegmann-Wessels; Georg Herrler
Journal:  Glycoconj J       Date:  2006-02       Impact factor: 2.916

5.  Human coronavirus 229E infects polarized airway epithelia from the apical surface.

Authors:  G Wang; C Deering; M Macke; J Shao; R Burns; D M Blau; K V Holmes; B L Davidson; S Perlman; P B McCray
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

6.  The viral spike protein is not involved in the polarized sorting of coronaviruses in epithelial cells.

Authors:  J W Rossen; R de Beer; G J Godeke; M J Raamsman; M C Horzinek; H Vennema; P J Rottier
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

7.  Infection of human airway epithelia with H1N1, H2N2, and H3N2 influenza A virus strains.

Authors:  V A Slepushkin; P D Staber; G Wang; P B McCray; B L Davidson
Journal:  Mol Ther       Date:  2001-03       Impact factor: 11.454

Review 8.  The molecular biology of coronaviruses.

Authors:  M M Lai; D Cavanagh
Journal:  Adv Virus Res       Date:  1997       Impact factor: 9.937

Review 9.  The molecular dynamics of feline coronaviruses.

Authors:  P J Rottier
Journal:  Vet Microbiol       Date:  1999-09-01       Impact factor: 3.293

Review 10.  Coronavirus entry and release in polarized epithelial cells: a review.

Authors:  Yingying Cong; Xiaofeng Ren
Journal:  Rev Med Virol       Date:  2014-04-16       Impact factor: 6.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.